Yuan Xia

1.3k total citations
70 papers, 856 citations indexed

About

Yuan Xia is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Yuan Xia has authored 70 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 15 papers in Hematology and 14 papers in Immunology. Recurrent topics in Yuan Xia's work include Systemic Lupus Erythematosus Research (5 papers), Multiple Myeloma Research and Treatments (5 papers) and MicroRNA in disease regulation (5 papers). Yuan Xia is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Multiple Myeloma Research and Treatments (5 papers) and MicroRNA in disease regulation (5 papers). Yuan Xia collaborates with scholars based in China, Australia and Japan. Yuan Xia's co-authors include Jun Li, Weizhen Huang, Xiaomei Li, Jin‐Hui Tao, Xiang-Pei Li, Xuan Fang, Yunming Tian, Xiaohong Guo, Kailin Xu and Jianlin Qiao and has published in prestigious journals such as Blood, Immunity and Cancer.

In The Last Decade

Yuan Xia

61 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan Xia China 17 444 225 187 91 79 70 856
Yan Meng China 18 584 1.3× 176 0.8× 216 1.2× 44 0.5× 101 1.3× 41 1.2k
Michele Scuruchi Italy 21 435 1.0× 176 0.8× 238 1.3× 26 0.3× 89 1.1× 54 1.1k
Anfei Huang China 17 358 0.8× 163 0.7× 312 1.7× 35 0.4× 145 1.8× 28 846
Xuejiao Yang China 14 483 1.1× 150 0.7× 135 0.7× 92 1.0× 98 1.2× 47 969
Lingling Shu China 14 274 0.6× 125 0.6× 87 0.5× 46 0.5× 74 0.9× 35 596
Tracy L. Deem United States 12 484 1.1× 101 0.4× 436 2.3× 57 0.6× 87 1.1× 13 1.1k
Ye Zhao China 17 575 1.3× 147 0.7× 300 1.6× 67 0.7× 141 1.8× 33 1.3k
Mikhail Menshikov Russia 20 379 0.9× 174 0.8× 159 0.9× 30 0.3× 74 0.9× 79 981
Xianyi Meng China 15 350 0.8× 215 1.0× 208 1.1× 26 0.3× 119 1.5× 22 769

Countries citing papers authored by Yuan Xia

Since Specialization
Citations

This map shows the geographic impact of Yuan Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Xia more than expected).

Fields of papers citing papers by Yuan Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Xia. The network helps show where Yuan Xia may publish in the future.

Co-authorship network of co-authors of Yuan Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Xia. A scholar is included among the top collaborators of Yuan Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Xia. Yuan Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Yang, Bo Jin, Tianyang Zhang, et al.. (2025). LDHA facilitates immune escape in bladder cancer through H4K5 lactylation-dependent upregulation of PD-L1. Biochemical Pharmacology. 243(Pt 2). 117553–117553.
3.
Xia, Yuan, et al.. (2025). Infantile epileptic spasms syndrome: an etiologic study of 361 patients with infantile epileptic spasms syndrome. Frontiers in Pediatrics. 12. 1522079–1522079. 1 indexed citations
4.
Xia, Yuan, et al.. (2025). Therapeutic Potential of Flavonoids and Flavonoid-Rich Compounds in Irritable Bowel Syndrome. Drug Design Development and Therapy. Volume 19. 4895–4910.
6.
Xia, Yuan, Min Shi, Na Shen, et al.. (2024). Tigit: The Potential Mechanisms of Relapse in Multiple Myeloma Following Anti-BCMA CAR-T Therapy and a Promising Target for Improving CAR-T Efficacy. Blood. 144(Supplement 1). 2033–2033. 1 indexed citations
7.
Xia, Yuan, Li Wang, Ying Xu, et al.. (2024). Mesenchymal stem cell infusion for enhancing hematopoietic recovery and addressing cytopenias in CAR-T cell therapy. Stem Cell Research & Therapy. 15(1). 333–333. 2 indexed citations
8.
Xia, Yuan, et al.. (2023). Research hotspots and trend analysis of abdominal pain in inflammatory bowel disease: a bibliometric and visualized analysis. Frontiers in Pharmacology. 14. 1220418–1220418. 5 indexed citations
9.
Sun, Tao, Guosheng Li, Yuan Xia, et al.. (2023). DEX‐Induced SREBF1 Promotes BMSCs Differentiation into Adipocytes to Attract and Protect Residual T‐Cell Acute Lymphoblastic Leukemia Cells After Chemotherapy. Advanced Science. 10(19). e2205854–e2205854. 2 indexed citations
10.
Wang, Zhangjie, Yuan Xia, Yang Wang, et al.. (2023). The E3 ligase TRIM26 suppresses ferroptosis through catalyzing K63-linked ubiquitination of GPX4 in glioma. Cell Death and Disease. 14(10). 695–695. 52 indexed citations
11.
Yang, Jing, et al.. (2023). Isoproterenol pre-treatment improve the therapeutic efficacy of cardiosphere-derived cells transplantation for myocardial infarction. Journal of Thoracic Disease. 15(6). 3089–3105. 1 indexed citations
12.
Xia, Yuan, Na Shen, Run Zhang, et al.. (2023). High-risk multiple myeloma predicted by circulating plasma cells and its genetic characteristics. Frontiers in Oncology. 13. 1083053–1083053. 6 indexed citations
13.
Xia, Yuan, et al.. (2023). Single-cell transcriptomic atlas throughout anti-BCMA CAR-T therapy in patients with multiple myeloma. Frontiers in Immunology. 14. 1278749–1278749. 3 indexed citations
14.
Ding, Ying, Yuan Xia, Jiachen Gao, et al.. (2022). OCT4, SOX2 and NANOG co-regulate glycolysis and participate in somatic induced reprogramming. Cytotechnology. 74(3). 371–383. 14 indexed citations
15.
Fang, Xuan, Yuan Xia, Manyun Li, et al.. (2022). ATP-Activated P2X7R Promote the Attack of Acute Gouty Arthritis in Rats Through Activating NLRP3 Inflammasome and Inflammatory Cytokine Production. Journal of Inflammation Research. Volume 15. 1237–1248. 13 indexed citations
16.
Chen, Qianbo, et al.. (2022). Acteoside protects retinal ganglion cells from experimental glaucoma by activating the PI3K/AKT signaling pathway via caveolin 1 upregulation. Annals of Translational Medicine. 10(6). 312–312. 18 indexed citations
17.
Su, Xiuhua, Tao Sun, Meng Li, et al.. (2022). Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape. Journal of Translational Medicine. 20(1). 378–378. 3 indexed citations
18.
Tao, Jin‐Hui, Xuan Fang, Yuan Xia, et al.. (2018). Changes of Treg/Th17 Ratio in Spleen of Acute Gouty Arthritis Rat Induced by MSU Crystals. Inflammation. 41(5). 1955–1964. 46 indexed citations
19.
Sun, Aihua, et al.. (2015). MicroRNA-197 reverses the drug resistance of fluorouracil-induced SGC7901 cells by targeting mitogen-activated protein kinase 1. Molecular Medicine Reports. 12(4). 5019–5025. 25 indexed citations
20.
Qiao, Jianlin, Yujin Huang, Yuan Xia, et al.. (2015). Busulfan and cyclosphamide induce liver inflammation through NLRP3 activation in mice after hematopoietic stem cell transplantation. Scientific Reports. 5(1). 17828–17828. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026